Rates of grade three or higher TEAEs have been related between the trastuzumab deruxtecan and T-DM1 arms (56.4% vs 51.7%, site (www.ninisite.com) respectively). Study authors noted that the charges of interstitial lung disease (ILD) and pneumonitis were in step with…